Neurosciences

PRA has conducted CNS clinical trials in more than 20 indications, with extensive experience in:

• Pain
• Alzheimer's/Vascular Dementia
• Epilepsy
• ADHD
• Multiple Sclerosis
• Parkinson's Disease

Our specialists perform complex neurobehavioral assessments employing effective, consistent, and relevant rating scales.

The novel ADHD transdermal patch, Daytrana^®, came to market in the US in 2006 after PRA provided the sponsor with full clinical support from Phase I through product registration. During the past 5 years, PRA has conducted over 300 studies and 80 consulting projects in neurosciences.

Phase I – Phase IV Clinical Trial Experience

Close to 45,000 subjects have participated in these trials.